Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:

Sunday, August 21, 2016

Resolvins, generated naturally from fish oil, show promise as anti-inflammation treatment

Would this also prevent the inflammation in our arteries? Stop the need for statin treatment?

Roswell Park Cancer Institute News
Excessive inflammation contributes to a variety of diseases, including cancer. The class of molecules known as resolvins appears to modify disease progression by decreasing inflammation, offering a potential therapeutic option, according to a recent review article published in the World Journal of Clinical Cases and co–authored by Kazuaki Takabe, MD, PhD, FACS, Clinical Chief of Breast Surgery at Roswell Park Cancer Institute. Resolvins are produced when the body metabolizes omega–3 fatty acids, which are found naturally in fish oil and vegetable oil. The scientists examined a number of studies evaluating the role of these molecules in reducing acute and chronic inflammation, which has been associated with diseases including gastroenteritis, hepatitis, diabetes, neurological diseases and cancer. “Resolvins have been shown to play a central anti–inflammatory role, and may have the clinical potential to slow the progression of diseases related to inflammation, including cancer,” says Dr. Takabe. “Currently, there are only a small number of studies that investigate the correlation between resolvins and cancer in humans. Given their unique function with minimal side effects, resolvins could represent a new class of anti–inflammatory drugs.” The authors note that further study will be required in order to develop therapies that take advantage of this anti–inflammatory capability of resolvins.

No comments:

Post a Comment